Loading...
V1b receptor antagonist SSR149415 and naltrexone synergistically decrease excessive alcohol drinking in male and female mice
BACKGROUND: A recent clinical trial found that pharmacological blockade of V1b receptors reduces alcohol relapse in alcohol-dependent patients. SSR149415 is a selective V1b receptor antagonist that has potential for development as an alcohol dependency treatment. In this study, we investigated wheth...
Na minha lista:
| Udgivet i: | Alcohol Clin Exp Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5750120/ https://ncbi.nlm.nih.gov/pubmed/29105118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13544 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|